Site Selection for Intracutaneous Saline Delivery

Completed · Not applicable

Conditions studied: Intracutaneous Drug Delivery

In brief

The goal of this exploratory study is to select the optimal body site for intracutaneous delivery of 0.5 milliliters of saline from the FLUGEN 101.2 microneedle-based device.

Key facts

Study ID

NCT01767324

Run by

FluGen Inc

People needed

12

Starts

2012-12-01

Expected to finish

2012-12-01

Last updated by the study team

2017-08-02

Who can join

Age: 18 and older, up to 49. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Able to read and/or understand and sign the Informed Consent Form

You may not qualify if…

• Medical history of acute or chronic skin disease
• Active skin allergy or acute skin infection, tattoo(s), scars, sunburn or skin abnormalities at any prospective injection site
• Hirsute at any prospective injection site
• Diabetes
• High levels of anxiety or depression or history of psychosis
• Abuse of alcohol or use of other drugs of abuse including tobacco
• Pregnant or breastfeeding women
• Any medical condition that may interfere with study protocol adherence including completion of study activities
• Foreseeable inability to complete the study as scheduled.

Where it is running

• Accelovance Inc — Melbourne, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.